NCT06397573

Ablative Stereotactic MR-Guided Adaptive Reirradiation

Phase 1 Trial of Ablative Stereotactic MR-Guided Adaptive Reirradiation for Abdominal and Pelvic Tumors

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Baptist Health South Florida · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This research study will enroll people who have cancer in their abdomen or pelvis that was treated previously with radiation therapy. The purpose of this research study is to test the safety and possible harms of treating tumors in these regions with another round of radiation therapy, called reirradiation or "reRT." The researchers want to find out what effects (good and bad) reRT has in people with cancer in the abdomen and pelvis.

Conditions

• Abdominal Cancer
• Pelvic Cancer

Interventions

Type	Name	Description
RADIATION	Reirradiation	Ablative reirradiation of 50 Gy in 5 fractions (5 sessions) that will occur once per day, either for 5 days in a row, or every other day.

Timeline

• Start date: 2024-06-05
• Primary completion: 2026-08-01
• Completion: 2027-06-01
• First posted: 2024-05-03
• Last updated: 2026-02-17

Locations

1 site across 1 country: United States